0       0

AMDA's 32nd Annual Symposium


B07 - Wound Dressings: An Evidence-Based Update for Practicing Providers


Mar 6, 2009 11:00am ‐ Mar 6, 2009 12:00pm

Standard: $24.00

Description

Commercial Support: This CME activity is supported by educational grants from ConvaTec

AMDCP Credit Designation:

This session has been approved for a total of 1 Clinical credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).

The American Medical Directors Association designates this educational activity fora maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Presenter(s): Paul Y. Takahashi, MD

Disclosure(s):
Paul Y. Takahashi, MD has no relevant financial relationships to disclose.

Session Description:
This session presents an evidence-based overview of common and newer wound dressings in long term care. Of the 5,000 wound dressings available, there are common themes and evidence that can guide a practicing provider to make good decisions. This session provides the fundamentals on wound dressing choices.

Learning Objectives:
  • Discuss how to differentiate between traditional and newer wounddressings
  • Evaluate the strength of the evidence for each wound dressing type
  • Recognize the limitations of the evidence behind the efficacy of manywound dressings
  • Apply the evidence from this symposium on wound dressings to clinicalpractice

References:
1. Palfreyman SJ,Nelson EA, Lochiel R, Michaels JA. Dressings for healing venous leg ulcers.Cochrane Database of Systematic Reviews. 2006;3:CD001103.
2. Talbot H, Del Mar C, Frangos J, Kumar K, Smart N, WaltersJ. Dressings and topical agents containing hyaluronic acid for wound healing.Cochrane Database of Systematic Reviews. 2008;2.
3. O'Meara S, Al-Kurdi D, Ovington LG. Antibiotics and antisepticsfor venous leg ulcers. Cochrane Database of Systematic Reviews. 2008;1.
4. Jull AB, Rodgers A, Walker N. Honey as a topical treatmentfor wounds. Cochrane Database of Systematic Reviews. 2008;2.
5. Robson MC, Phillips TJ, Falanga V, Odenheimer DJ, ParishLC, Jensen JL, et al. Randomized trial of topically applied repifermin(recombinant human keratinocyte growth factor-2) to accelerate wound healing invenous ulcers. Wound Repair & Regeneration. 2001 Sep-Oct
Sep-Oct;9(5):347-52.
6. Falanga V, Sabolinski M. A bilayered living skin construct(APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. WoundRepair & Regeneration. 1999 Jul-Aug
Jul-Aug;7(4):201-7.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content